Business Context and Reporting Period
Company: Harvard Bioscience, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 26, 2018
Reporting Period: The filing announces financial results for the three and six months ended June 30, 2018.
Key Financial Metrics
The provided text is a cover sheet for a Form 8-K and does not contain specific financial data. It references a press release (Exhibit 99.1) for details on revenue, profit, cash flow, margins, debt, and liquidity. Consequently, no numerical values for these metrics are available in the source text.
Material Changes
The filing text does not provide specific data regarding material changes versus prior comparable periods. It only indicates that such results were announced via a press release.
Guidance, Outlook, and Management Commentary
Management Action: On July 26, 2018, the company issued a press release and scheduled a conference call for 4:30 PM EST to discuss the results.
Legal Disclaimer: The information in Item 2.02 and the attached press release is not deemed "filed" under Section 18 of the Exchange Act and is not subject to the liabilities of that section, nor is it incorporated by reference in other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for actual revenue, net income, and cash flow figures for the periods ended June 30, 2018.
- Verify the details of the conference call held on July 26, 2018, for management commentary on operational trends.
- Confirm whether the press release contains updated forward-looking guidance or outlook statements.
- Check subsequent filings (e.g., 10-Q) for the audited or reviewed financial statements corresponding to this period.